443 results on '"Kong, Chuize"'
Search Results
2. PD-L1 expression and its correlation with tumor biomarkers in Chinese urothelial bladder cancer
3. NCAPG2 promotes prostate cancer malignancy and stemness via STAT3/c-MYC signaling
4. Retraction Note: METTL13 is downregulated in bladder carcinoma and suppresses cell proliferation, migration and invasion
5. Flavokawain A is a natural inhibitor of PRMT5 in bladder cancer
6. METTL14-mediated N6-methyladenosine modification of ITGB4 mRNA inhibits metastasis of clear cell renal cell carcinoma
7. Long non-coding RNA LINC02446 suppresses the proliferation and metastasis of bladder cancer cells by binding with EIF3G and regulating the mTOR signalling pathway
8. STAT3 regulates miR93-mediated apoptosis through inhibiting DAPK1 in renal cell carcinoma
9. Survival after radical cystectomy for bladder cancer: Multicenter comparison between minimally invasive and open approaches
10. UNC5B mediates G2/M phase arrest of bladder cancer cells by binding to CDC14A and P53
11. Correction to: USP13 functions as a tumor suppressor by blocking the NF-kB-mediated PTEN downregulation in human bladder cancer
12. Down-regulation LncRNA-SNHG15 contributes to proliferation and invasion of bladder cancer cells
13. A novel immune-related gene pair prognostic signature for predicting overall survival in bladder cancer
14. METTL13 inhibits progression of clear cell renal cell carcinoma with repression on PI3K/AKT/mTOR/HIF-1α pathway and c-Myc expression
15. PLK1 promotes proliferation and suppresses apoptosis of renal cell carcinoma cells by phosphorylating MCM3
16. The circINTS4/miR-146b/CARMA3 axis promotes tumorigenesis in bladder cancer
17. A long non-coding RNA signature to improve prognostic prediction in clear cell renal cell carcinoma
18. Application of fluorescence in situ hybridization in the detection of bladder transitional-cell carcinoma: A multi-center clinical study based on Chinese population
19. Correction to: ERCC6L that is up-regulated in high grade of renal cell carcinoma enhances cell viability in vitro and promotes tumor growth in vivo potentially through modulating MAPK signalling pathway
20. Correction: PLK1 promotes proliferation and suppresses apoptosis of renal cell carcinoma cells by phosphorylating MCM3
21. Correction: UNC5B mediates G2/M phase arrest of bladder cancer cells by binding to CDC14A and P53
22. ERCC6L that is up-regulated in high grade of renal cell carcinoma enhances cell viability in vitro and promotes tumor growth in vivo potentially through modulating MAPK signalling pathway
23. HIF-1α-dependent miR-424 induction confers cisplatin resistance on bladder cancer cells through down-regulation of pro-apoptotic UNC5B and SIRT4
24. USP13 functions as a tumor suppressor by blocking the NF-kB-mediated PTEN downregulation in human bladder cancer
25. PAGE4 promotes prostate cancer cells survive under oxidative stress through modulating MAPK/JNK/ERK pathway
26. Abstract 6658: Prevalence of PD-L1 expression and its correlation with tumor biomarkers in the Chinese muscle invasive urothelial bladder carcinoma patients
27. Supplementary Table 2 from Stress-Response Protein RBM3 Attenuates the Stem-like Properties of Prostate Cancer Cells by Interfering with CD44 Variant Splicing
28. Supplementary Figure 2 from Stress-Response Protein RBM3 Attenuates the Stem-like Properties of Prostate Cancer Cells by Interfering with CD44 Variant Splicing
29. Supplementary Figure 1 from Stress-Response Protein RBM3 Attenuates the Stem-like Properties of Prostate Cancer Cells by Interfering with CD44 Variant Splicing
30. Data from Stress-Response Protein RBM3 Attenuates the Stem-like Properties of Prostate Cancer Cells by Interfering with CD44 Variant Splicing
31. Supplementary Figure 4 from Stress-Response Protein RBM3 Attenuates the Stem-like Properties of Prostate Cancer Cells by Interfering with CD44 Variant Splicing
32. Supplementary documents from Stress-Response Protein RBM3 Attenuates the Stem-like Properties of Prostate Cancer Cells by Interfering with CD44 Variant Splicing
33. Supplementary Figure 3 from Stress-Response Protein RBM3 Attenuates the Stem-like Properties of Prostate Cancer Cells by Interfering with CD44 Variant Splicing
34. Supplementary Table 1 from Stress-Response Protein RBM3 Attenuates the Stem-like Properties of Prostate Cancer Cells by Interfering with CD44 Variant Splicing
35. Supplementary Figure 5 from Stress-Response Protein RBM3 Attenuates the Stem-like Properties of Prostate Cancer Cells by Interfering with CD44 Variant Splicing
36. Deacetylation of Septin4 by SIRT2 (Silent Mating Type Information Regulation 2 Homolog-2) Mitigates Damaging of Hypertensive Nephropathy
37. Long non-coding RNA LINC02446 suppresses the proliferation and metastasis of bladder cancer cells by binding with EIF3G and regulating the mTOR signalling pathway
38. Long non-coding RNA ZEB1-AS1 regulates miR-200b/FSCN1 signaling and enhances migration and invasion induced by TGF-β1 in bladder cancer cells
39. RUNX2 interacts with SCD1 and activates Wnt/β‐catenin signaling pathway to promote the progression of clear cell renal cell carcinoma
40. hZIP1 that is down-regulated in clear cell renal cell carcinoma is negatively associated with the malignant potential of the tumor
41. High expression of polo-like kinase 1 is associated with the metastasis and recurrence in urothelial carcinoma of bladder
42. c-Jun is involved in interstitial cystitis antiproliferative factor (APF)-induced growth inhibition of human bladder cancer T24 cells
43. An RNA-binding protein-related risk signature can predict the prognosis and tumor immunity of patients with testicular germ cell tumors
44. RUNX2 interacts with SCD1 and activates Wnt/β‐catenin signaling pathway to promote the progression of clear cell renal cell carcinoma.
45. EIF2C, Dicer, and Drosha are up-regulated along tumor progression and associated with poor prognosis in bladder carcinoma
46. Fascin is a predictor for invasiveness and recurrence of urothelial carcinoma of bladder
47. An HDAC9-associated immune-related signature predicts bladder cancer prognosis
48. Additional file 3 of METTL14-mediated N6-methyladenosine modification of ITGB4 mRNA inhibits metastasis of clear cell renal cell carcinoma
49. Additional file 4 of METTL14-mediated N6-methyladenosine modification of ITGB4 mRNA inhibits metastasis of clear cell renal cell carcinoma
50. Additional file 2 of METTL14-mediated N6-methyladenosine modification of ITGB4 mRNA inhibits metastasis of clear cell renal cell carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.